These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2225341)

  • 1. Formation of cyclic deoxyguanosine adducts in Chinese hamster ovary cells by acrolein and crotonaldehyde.
    Foiles PG; Akerkar SA; Miglietta LM; Chung FL
    Carcinogenesis; 1990 Nov; 11(11):2059-61. PubMed ID: 2225341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde.
    Chung FL; Young R; Hecht SS
    Cancer Res; 1984 Mar; 44(3):990-5. PubMed ID: 6318992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of cyclic nucleic acid adducts from some simple alpha, beta-unsaturated carbonyl compounds and cyclic nitrosamines.
    Chung FL; Hecht SS; Palladino G
    IARC Sci Publ; 1986; (70):207-25. PubMed ID: 3793173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cyclic 1,N2-propanodeoxyguanosine adducts in DNA of rats treated with N-nitrosopyrrolidine and mice treated with crotonaldehyde.
    Chung FL; Young R; Hecht SS
    Carcinogenesis; 1989 Jul; 10(7):1291-7. PubMed ID: 2736720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.
    Maccubbin AE; Lee L; Struck RF; Gurtoo HL
    Chem Biol Interact; 1992 Sep; 84(1):21-35. PubMed ID: 1394614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo.
    Schuler BD; Eder E
    Arch Toxicol; 2000 Sep; 74(7):404-14. PubMed ID: 11043496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 32P-postlabeling method for simultaneous detection and quantification of exocyclic etheno and propano adducts in DNA.
    Nath RG; Chen HJ; Nishikawa A; Young-Sciame R; Chung FL
    Carcinogenesis; 1994 May; 15(5):979-84. PubMed ID: 8200104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of 1,N2-propano-2'-deoxyguanosine adducts derived from acrolein and crotonaldehyde in human placenta and leukocytes by isotope dilution nanoflow LC nanospray ionization tandem mass spectrometry.
    Chen HJ; Lin WP
    Anal Chem; 2009 Dec; 81(23):9812-8. PubMed ID: 19899782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of TD(50) and comparison with 1,N(2)-propanodeoxyguanosine adduct levels.
    Eder E; Budiawan
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):883-8. PubMed ID: 11489755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of the acrolein-derived 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with 3-(N-carbethoxy-N-nitrosamino)propionaldehyde.
    Chung FL; Krzeminski J; Wang M; Chen HJ; Prokopczyk B
    Chem Res Toxicol; 1994; 7(1):62-7. PubMed ID: 8155826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an immunoassay for cyclic acrolein deoxyguanosine adducts to assess their formation in DNA of Salmonella typhimurium under conditions of mutation induction by acrolein.
    Foiles PG; Akerkar SA; Chung FL
    Carcinogenesis; 1989 Jan; 10(1):87-90. PubMed ID: 2642752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of acrolein and crotonaldehyde DNA adducts in cultured human cells and canine peripheral blood lymphocytes by 32P-postlabeling and nucleotide chromatography.
    Wilson VL; Foiles PG; Chung FL; Povey AC; Frank AA; Harris CC
    Carcinogenesis; 1991 Aug; 12(8):1483-90. PubMed ID: 1860170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
    Schuler D; Budiawan B; Eder E
    Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues.
    Nath RG; Ocando JE; Chung FL
    Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 1,N2-propanodeoxyguanosine adducts of 2-hexenal in organs of Fischer 344 rats by a 32P-post-labeling technique.
    Schuler D; Eder E
    Carcinogenesis; 1999 Jul; 20(7):1345-50. PubMed ID: 10383910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 32P-postlabeling analysis of binding of the cyclophosphamide metabolite, acrolein, to DNA.
    Maccubbin AE; Caballes L; Scappaticci F; Struck RF; Gurtoo HL
    Cancer Commun; 1990; 2(6):207-11. PubMed ID: 2378783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of acrolein and acrolein-induced DNA adducts.
    Liu XY; Zhu MX; Xie JP
    Toxicol Mech Methods; 2010 Jan; 20(1):36-44. PubMed ID: 20158384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (E)-2-hexenal-induced DNA damage and formation of cyclic 1,N2-(1,3-propano)-2'-deoxyguanosine adducts in mammalian cells.
    Gölzer P; Janzowski C; Pool-Zobel BL; Eisenbrand G
    Chem Res Toxicol; 1996; 9(7):1207-13. PubMed ID: 8902278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,N2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage.
    Kurtz AJ; Lloyd RS
    J Biol Chem; 2003 Feb; 278(8):5970-6. PubMed ID: 12502710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.